Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Aarhus | OTHER |
| Novo Nordisk A/S | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Aim: To compare the surgical method of En Bloc resection to the conventional transurethral resection of non-muscle invasive bladder cancer (NMIBC) in terms of complete removal of tumour, specimen quality, and pathological certainty.
Background: NMIBC is a common disease with a 5-year recurrence rate reported as high as 64%. The cornerstone in the treatment of NMIBC is transurethral resection (TURB) where the tumour is dissected in pieces, removed from the bladder, and pathologically examined for potential muscle invasion. As the tumour is fragmented before removal, the method violates basic oncological principles and compromises pathological examination. Hence, TURB is possibly part of the mechanism causing recurrences. En Bloc resection (EBR), where the tumour is removed in toto, can potentially overcome the flaws of conventional TURB, but large randomized trials are needed.
Methods: This project will be a multicentre randomised controlled clinical trial comparing EBR to conventional TURB. Patients with suspected NMIBC tumours with largest tumour diameter ≥1cm and ≤6cm will be randomised to either the intervention group, thus undergoing EBR, or the control group, undergoing conventional TURB. The investigators intend to include 220 patients in total, 110 patients in each group. The RCT will be initiated in 2022.
Perspectives: If EBR can be shown to remove bladder tumours with better pathological quality and certainty, this could potentially spare patients from undergoing surgeries in the future, thereby reducing costs for both patients and society.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| En Bloc | Experimental | The bladder tumour will be resected en bloc and removed in total, if possible. |
|
| Conventional TURB | Active Comparator | The bladder tumour will be removed by conventional piecemeal resection. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| En Bloc resection | Procedure | Tumour is resected and removed from the bladder in one piece, if possible. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Unaltered pathological T-stage | Proportion of patients with unaltered pathological T-stage following central pathology revision, reTURB, or cystectomy compared to initial T-stage description from TURB. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Detrusor muscle in specimen | Prevalence of detrusor muscle in specimen by pathological examination | Within one week from surgery |
| Recurrence free survival | Proportion of patients with recurrences at 4 months follow-up cystoscopy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Urology, Aalborg University Hospital | Aalborg | 9100 | Denmark | |||
| Department of Urology, Aarhus University Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000093284 | Non-Muscle Invasive Bladder Neoplasms |
| ID | Term |
|---|---|
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Conventional TURB | Procedure | Tumour is resected piecemeal. |
|
| 4 months |
| Aarhus |
| 8200 |
| Denmark |
| Department of Urology, Herlev Hospital | Herlev | Denmark |
| Department of Urology, Regional Hospital Gødstrup | Holstebro | 7500 | Denmark |
| Department of Urology, Odense University Hospital | Odense | 5000 | Denmark |
| Department of Urology, Zealand University Hospital | Roskilde | 4000 | Denmark |
| Dept. of Urology, Hospital Lilelbælt, Vejle | Vejle | 7100 | Denmark |
| Dept. of Urology, North Estonia Medical Centre | Tallinn | 13419 | Estonia |
| Dept. of Urology, Turku University Hospital | Turku | 20521 | Finland |
| Urological Center, Paula Stradina Clinical University Hospital | Riga | LV-1002 | Latvia |
| Department of Urology, Vestfold Hospital | Tønsberg | 3103 | Norway |
| D001749 |
| Urinary Bladder Neoplasms |
| D014571 | Urologic Neoplasms |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |